Thrice-Weekly Clarithromycin-Containing Regimen for Treatment of Mycobacterium kansasii Lung Disease: Results of a Preliminary Study
Open Access
- 1 November 2003
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 37 (9) , 1178-1182
- https://doi.org/10.1086/378742
Abstract
We initiated a prospective trial of an intermittent clarithromycin-containing regimen for the treatment of patients with Mycobacterium kansasii lungKeywords
This publication has 13 references indexed in Scilit:
- Early Results (at 6 Months) with Intermittent Clarithromycin-Including Regimens for Lung Disease Due to Mycobacterium avium ComplexClinical Infectious Diseases, 2000
- Nontuberculous MycobacteriaAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Lifestyle, Stress, and Genes in Peptic Ulcer DiseaseArchives of internal medicine (1960), 1998
- Diagnosis and Treatment of Disease Caused by Nontuberculous MycobacteriaAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Emergence of Mycobacterium kansasii as the Leading Mycobacterial Pathogen Isolated Over a 20-Year Period at a Midwestern Veterans Affairs HospitalClinical Infectious Diseases, 1996
- Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease.American Journal of Respiratory and Critical Care Medicine, 1994
- Rifampin-Resistant Mycobacterium kansasiiClinical Infectious Diseases, 1994
- Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of treatment with rifampicin and ethambutol. Research Committee, British Thoracic Society.Thorax, 1994
- Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC systemAntimicrobial Agents and Chemotherapy, 1992
- A Demographic Study of Disease due to Mycobacterium kansasii or M intracellulare-avium in TexasChest, 1979